Morphic Therapeutic
MORF
$29.62
Share price
3.17%
Change (1 day)
-38.92%
Change (1 year)
Categories
Operating Margin for Morphic Therapeutic (MORF)
Operating Margin as of May 2024 (TTM): -102.87%
According to Morphic Therapeutic's latest financial reports and stock price the company's current Operating Margin is -102.87%. At the end of 2022 the company had an Operating Margin of -83.29%.
Operating Margin history for Morphic Therapeutic from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -83.29% | -82.74% |
| 2021 | -482.68% | 376.07% |
| 2020 | -101.39% | -59.42% |
| 2019 | -249.84% | -64.79% |
| 2018 | -709.68% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -64.65% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 8,057.04% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.